Association Between Titin Loss-of-Function Variants and Early-Onset Atrial Fibrillation.

Choi SH, Weng LC, Roselli C, Lin H, Haggerty CM, Shoemaker MB, Barnard J, Arking DE, Chasman DI, Albert CM, Chaffin M, Tucker NR, Smith JD, Gupta N, Gabriel S, Margolin L, Shea MA, Shaffer CM, Yoneda ZT, Boerwinkle E, Smith NL, Silverman EK, Redline S, Vasan RS, Burchard EG, Gogarten SM, Laurie C, Blackwell TW, Abecasis G, Carey DJ, Fornwalt BK, Smelser DT, Baras A, Dewey FE, Jaquish CE, Papanicolaou GJ, Sotoodehnia N, Van Wagoner DR, Psaty BM, Kathiresan S, Darbar D, Alonso A, Heckbert SR, Chung MK, Roden DM, Benjamin EJ, Murray MF, Lunetta KL, Lubitz SA, Ellinor PT, DiscovEHR study and the NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium
JAMA. 2018 320 (22): 2354-2364

PMID: 30535219 · PMCID: PMC6436530 · DOI:10.1001/jama.2018.18179

MeSH Terms (14)

Adult Age of Onset Atrial Fibrillation Case-Control Studies Connectin Female Genetic Predisposition to Disease Genome-Wide Association Study Heterozygote Humans Loss of Function Mutation Male Middle Aged Quality Control

Connections (1)

This publication is referenced by other Labnodes entities: